Finance

Lists
Why is LABT down 21.38%?
Dive Deeper
LABT:NASDAQ
Lakewood-amedex Biotherapeutics Inc
$0.28
-21.38%
(-0.077) 1D
$0.27
-4.36% (-0.012)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LABT...
Open
$0.33
High
$0.34
Low
$0.24
Mkt. cap
667.71K
Avg. vol.
30.04M
Volume
2.02M
52-wk high
$98.20
52-wk low
$0.17
EPS
-$2.91
No. of employees
5
Open
$0.33
High
$0.34
Low
$0.24
Mkt. cap
667.71K
Avg. vol.
30.04M
Volume
2.02M
52-wk high
$98.20
52-wk low
$0.17
EPS
-$2.91
No. of employees
5
News stories
From web sources and news partners
About Lakewood-amedex Biotherapeutics Inc
CEO-
Employees5
Founded2006
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitelakewoodamedex.com
Analyst ratings
Based on 1 analyst giving stock ratings to LABT in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for LABT in the last 3 months
Highest
Current $0.28
$3.00 (+962.32%)
Average
$3.00 (+962.32%)
Lowest
$3.00 (+962.32%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Initiated
$3.00
+962.3%
10/28/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
752.93K
185.73K
182.15K
503.02K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.13M
525.17K
703.44K
3.29M
Operating expense
1.88M
712.06K
886.75K
3.79M
Total operating expenses
1.88M
712.06K
886.75K
3.79M
Operating income
-1.88M
-712.06K
-886.75K
-3.79M
Other non operating income
-
-
600.00
-
EBT including unusual items
-1.91M
-744.92K
-923.29K
-3.77M
EBT excluding unusual items
-1.91M
-744.92K
-923.29K
-3.77M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.91M
-744.92K
-923.29K
-3.77M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
10.97K
4.95K
1.08K
28.28K
Interest expense
-37.81K
-37.81K
-38.22K
-10.63K
Net interest expenses
-26.84K
-32.86K
-37.14K
17.65K
Depreciation and amortization charges
1.16K
1.16K
1.16K
1.16K
EBITDA
-1.88M
-710.90K
-885.59K
-3.79M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps